Prehospital blood transfusion for haemorrhagic shock

Affiliations

¹ Tulane University School of Medicine, Department of Surgery, New Orleans, LA 70112, USA. Electronic address: jsimpson3@tulane.edu.
² Tulane University School of Medicine, Department of Surgery, New Orleans, LA 70112, USA.
³ WakeMed Health and Hospitals, Raleigh, NC, USA; University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
⁴ University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.

Comment

John T Simpson et al. Lancet Haematol. 2022 Jun.

. 2022 Jun;9(6):e396-e397.

doi: 10.1016/S2352-3026(22)00112-0.

¹ Tulane University School of Medicine, Department of Surgery, New Orleans, LA 70112, USA. Electronic address: jsimpson3@tulane.edu.
² Tulane University School of Medicine, Department of Surgery, New Orleans, LA 70112, USA.
³ WakeMed Health and Hospitals, Raleigh, NC, USA; University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
⁴ University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.

No abstract available

Conflict of interest statement

MP is the Chief Medical Officer for 410 Medical. VDM is the Director of Science and Clinical Research for 410 Medical.

Prehospital blood transfusion for haemorrhagic shock - Authors' reply.
Crombie N, Bishop J, Ives N, Perkins GD. Crombie N, et al. Lancet Haematol. 2022 Jun;9(6):e397. doi: 10.1016/S2352-3026(22)00137-5. Lancet Haematol. 2022. PMID: 35654073 No abstract available.

Resuscitation with blood products in patients with trauma-related haemorrhagic shock receiving prehospital care (RePHILL): a multicentre, open-label, randomised, controlled, phase 3 trial.
Crombie N, Doughty HA, Bishop JRB, Desai A, Dixon EF, Hancox JM, Herbert MJ, Leech C, Lewis SJ, Nash MR, Naumann DN, Slinn G, Smith H, Smith IM, Wale RK, Wilson A, Ives N, Perkins GD; RePHILL collaborative group. Crombie N, et al. Lancet Haematol. 2022 Apr;9(4):e250-e261. doi: 10.1016/S2352-3026(22)00040-0. Epub 2022 Mar 7. Lancet Haematol. 2022. PMID: 35271808 Free PMC article. Clinical Trial.